Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance.
- befree-2016 importedOn "2016-02-19" NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance.
- NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_assertion wasGeneratedBy ECO_0000203 NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance.
- NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_assertion wasDerivedFrom befree-2016 NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance.
- NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_assertion SIO_000772 20385121 NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance.
- NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_assertion evidence source_evidence_literature NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance.
- NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_assertion description "[We have investigated the therapeutic properties of 5-[[6-[(2-fluorophenyl)-methoxy]-2-napthalenyl]-methyl]-2,4-thiazolidinedione (MCC-555) a PPARgamma agonist in human colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805610.RAeaRYEK75U-3bgftIQkdYFYi-3K_HTnxYLzN_c2Mh9-w130_provenance.